亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)卡立普多原料生產(chǎn)廠家供應(yīng)

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
過期 長(zhǎng)期有效
更新 2012-10-23 14:32
 

武漢大華偉業(yè)醫(yī)藥化工公司

企業(yè)會(huì)員第14年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

產(chǎn)品名稱:卡立普多 化學(xué)名:卡立普多 用途:其他原料藥

規(guī)格:醫(yī)藥級(jí) 質(zhì)量標(biāo)準(zhǔn):CP2010 外觀性狀:白色粉末

含量:99% 保質(zhì)期:24(月) CAS78-44-4



卡立普多 
英文名  Carisoprodol

產(chǎn)品名稱 卡立普多
分子式  C12H24N2O4
分子量  260.33
CAS登錄號(hào)  78-44-4
EINECS登錄號(hào)  201-118-7
物理化學(xué)性質(zhì)
熔點(diǎn)  92-92℃
水溶性  <0.1 G/100 ML AT 19.5℃
USP29
25kg/drum

作用與作用機(jī)制:   本品為中樞性肌肉松弛藥,并具有鎮(zhèn)靜作用,其骨骼肌松弛的確切機(jī)制尚未明了,似與其鎮(zhèn)靜作用有關(guān)。 本品對(duì)痙攣性或運(yùn)動(dòng)障礙性運(yùn)動(dòng)病無效。 

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)氨茶堿原料廠家供應(yīng) 供應(yīng)溶菌酶原料藥廠家供應(yīng) 供應(yīng)磺胺嘧啶銀原料藥廠家供應(yīng) 供應(yīng)鹽酸苯海拉明原料藥廠家供應(yīng) 供應(yīng)L-鳥氨酸鹽酸鹽廠家供應(yīng) 供應(yīng)四磷酸腺二鳥苷原料藥-生產(chǎn)廠家供應(yīng) 供應(yīng)氯雷他定原料藥廠家供應(yīng) 供應(yīng)D-泛酸鈣廠家價(jià)格
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |